Efficacy and safety of bevacizumab in elderly patients with
metastatic colorectal cancer: results from the Czech
population-based registry

J 2014

Efficacy and safety of bevacizumab in elderly patients with metastatic colorectal cancer: results from the Czech population-based registry

SLAVÍČEK, Lubomír, Tomáš PAVLÍK, Jiří TOMÁŠEK, Zbyněk BORTLÍČEK, Tomáš BÜCHLER et. al.

Basic information

Original name

Efficacy and safety of bevacizumab in elderly patients with metastatic colorectal cancer: results from the Czech population-based registry

Authors

SLAVÍČEK, Lubomír (203 Czech Republic), Tomáš PAVLÍK (203 Czech Republic, belonging to the institution), Jiří TOMÁŠEK (203 Czech Republic), Zbyněk BORTLÍČEK (203 Czech Republic, belonging to the institution), Tomáš BÜCHLER (203 Czech Republic), Bohuslav MELICHAR (203 Czech Republic), Rostislav VYZULA (203 Czech Republic), Jana PRAUSOVÁ (203 Czech Republic), Jindřich FÍNEK (203 Czech Republic), Ondřej MÁJEK (203 Czech Republic, belonging to the institution) and Ladislav DUŠEK (203 Czech Republic, guarantor, belonging to the institution)

Edition

BMC Gastroenterology, London, BioMed Central, 2014, 1471-230X

Other information

Language

English

Type of outcome

Článek v odborném periodiku

Field of Study

30000 3. Medical and Health Sciences

Country of publisher

United Kingdom of Great Britain and Northern Ireland

Confidentiality degree

není předmětem státního či obchodního tajemství

Impact factor

Impact factor: 2.365

RIV identification code

RIV/00216224:14110/14:00075327

Organization unit

Faculty of Medicine

DOI

http://dx.doi.org/10.1186/1471-230X-14-53

UT WoS

000334417600002

Keywords in English

Anti-angiogenic therapy; Chemotherapy; Elderly patients; Overall survival; Progression-free survival

Abstract

V originále

V rámci práce bylo sledováno 3187 pacientů s mCRC léčených bevacizumabem v 1. linii z českého národního registru pacientů s mCRC. Cílem bylo porovnat účinnost a bezpečnost léčby v různých věkových kategoriích.

Citovat

SLAVÍČEK, Lubomír, Tomáš PAVLÍK, Jiří TOMÁŠEK, Zbyněk BORTLÍČEK, Tomáš BÜCHLER, Bohuslav MELICHAR, Rostislav VYZULA, Jana PRAUSOVÁ, Jindřich FÍNEK, Ondřej MÁJEK and Ladislav DUŠEK. Efficacy and safety of bevacizumab in elderly patients with metastatic colorectal cancer: results from the Czech population-based registry. BMC Gastroenterology. London: BioMed Central, 2014, vol. 14, No 53, p. 1-8. ISSN 1471-230X. Available from: https://dx.doi.org/10.1186/1471-230X-14-53.

@article{1180237,
   author = {Slavíček, Lubomír and Pavlík, Tomáš and Tomášek, Jiří and Bortlíček, Zbyněk and Büchler, Tomáš and Melichar, Bohuslav and Vyzula, Rostislav and Prausová, Jana and Fínek, Jindřich and Májek, Ondřej and Dušek, Ladislav},
   article_location = {London},
   article_number = {53},
   doi = {http://dx.doi.org/10.1186/1471-230X-14-53},
   keywords = {Anti-angiogenic therapy; Chemotherapy; Elderly patients; Overall survival; Progression-free survival},
   language = {eng},
   issn = {1471-230X},
   journal = {BMC Gastroenterology},
   title = {Efficacy and safety of bevacizumab in elderly patients with metastatic colorectal cancer: results from the Czech population-based registry},
   volume = {14},
   year = {2014}
}

TY  - JOUR
ID  - 1180237
AU  - Slavíček, Lubomír - Pavlík, Tomáš - Tomášek, Jiří - Bortlíček, Zbyněk - Büchler, Tomáš - Melichar, Bohuslav - Vyzula, Rostislav - Prausová, Jana - Fínek, Jindřich - Májek, Ondřej - Dušek, Ladislav
PY  - 2014
TI  - Efficacy and safety of bevacizumab in elderly patients with metastatic colorectal cancer: results from the Czech population-based registry
JF  - BMC Gastroenterology
VL  - 14
IS  - 53
SP  - 1-8
EP  - 1-8
PB  - BioMed Central
SN  - 1471230X
KW  - Anti-angiogenic therapy
KW  - Chemotherapy
KW  - Elderly patients
KW  - Overall survival
KW  - Progression-free survival
N2  - V rámci práce bylo sledováno 3187 pacientů s mCRC léčených bevacizumabem v 1. linii z českého národního registru pacientů s mCRC. Cílem bylo porovnat účinnost a bezpečnost léčby v různých věkových kategoriích.
ER  -

SLAVÍČEK, Lubomír, Tomáš PAVLÍK, Jiří TOMÁŠEK, Zbyněk BORTLÍČEK, Tomáš BÜCHLER, Bohuslav MELICHAR, Rostislav VYZULA, Jana PRAUSOVÁ, Jindřich FÍNEK, Ondřej MÁJEK and Ladislav DUŠEK. Efficacy and safety of bevacizumab in elderly patients with metastatic colorectal cancer: results from the Czech population-based registry. \textit{BMC Gastroenterology}. London: BioMed Central, 2014, vol.~14, No~53, p.~1-8. ISSN~1471-230X. Available from: https://dx.doi.org/10.1186/1471-230X-14-53.

Detailed Information on Publication Record